01056nas a2200301   4500000000100000000000100001008004100002653003100043653005600074653003500130653004200165653007100207653002500278653001100303653008100314653001100395653004200406653002600448100001700474700001400491700001500505700001100520245015500531250001500686300001400701490000700715020003200722       2022                            d10aAdministration, Inhalation10aAdrenergic beta-2 Receptor Agonists/adverse effects10a*Asthma/diagnosis/drug therapy10aBronchodilator Agents/adverse effects10a*Cardiovascular Diseases/chemically induced/diagnosis/epidemiology10aCase-Control Studies10aHumans10a*Pulmonary Disease, Chronic Obstructive/complications/diagnosis/drug therapy10aAsthma10achronic obstructive pulmonary disease10anested case–control1 aJ. Amegadzie1 aJ. Gamble1 aJ. Farrell1 aZ. Gao00aAssociation between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study  a2022/06/02  a1205-12170 v17  a1176-9106 (Print)
1176-9106